-
The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication
Wednesday, November 29, 2017
The FDA is alerting the public, health care providers, lab personnel, and lab test developers that biotin can significantly interfere with certain lab tests and cause incorrect test results which may go undetected.
Read More
-
FDA Alerts Consumers About Potentially Life-Threatening Health Problems Linked to Limbrel
Monday, November 27, 2017
The U.S. Food and Drug Administration is investigating serious adverse events involving Limbrel, a product in capsule form currently being marketed as a medical food to manage the metabolic processes associated with osteoarthritis.
Read More
-
FDA Statement: Impact of IV Fluid Shortages Following Hurricane Destruction
Monday, November 20, 2017
Update on the efforts by the FDA to address IV fluid shortages exacerbated by Hurricane Maria and advice for hospitals in managing the shortage
Read More
-
Baxter Issues A Voluntary Nationwide Recall For One Lot of Nexterone Injection Due To Presence Of Particulate Matter
Thursday, November 16, 2017
Baxter International Inc. announced today it is voluntarily recalling one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection – distributed between 8/23/2017 and 10/2/2017 in the United States to wholesalers/distributors and healthcare facilities – due to the potential presence of...
Read More
